The EBMT Annual Meeting is the most important annual event for research and education in the field of bone marrow transplantation in Europe. It includes the 32nd Meeting of the EBMT Nurses Group, the 15th Meeting of the EBMT Data Management Group, the 8th Meeting of the Quality Management Group, the 5th Paediatric Day and the 10th EBMT Patient & Family Day, which in turn will incorporate the 3rd Donor Day.
Attendance levels at EBMT Annual Meetings have grown significantly over recent years and it now attracts more than 4,000 participants, including international experts, scientists, physicians, nurses, statisticians, clinical research technicians, patients and processing laboratory personnel.
The scientific programme includes symposia, educational sessions and workshops covering the key issues relating to bone marrow and stem cell transplantation.
SCIENTIFIC PROGRAMME - TOPICS
The Scientific Programme will deal with most recent developments in autologous and allogeneic transplantation. Transplant will be viewed not as a stand-alone procedure, but as a part of a complex therapeutic program that includes molecularly targeted drugs, supportive therapies, cell selection, and gene-modified cell therapies.
The key message will be the integration among top level science, high technology (particularly cell and gene therapy), and clinical excellence.
1. Cell therapy / Cellular Therapy
2. Hematopoietic stem cells
3. Regenerative medicine
4. Gene Therapy
5. Non-hematopoietic stem cells
6. Stem cell mobilisation and Graft engineering
7. Apheresis stem cell collection and processing
8. Tumor stem cells
9. Stem cell source
10. Stem cell donor
11. Graft-versus-host disease – preclinical and animal models
12. Graft-versus-host disease – clinical
13. Infectious complications
14. Early complications / Late effects & quality of life
15. Conditioning regimen
16. Minimal residual disease, Tolerance, Chimerism and Immune reconstitution
17. Paediatric issues
18. Experimental stem cell transplantation
19. Acute leukaemia
20. Aplastic anaemia
21. Autoimmune diseases
22. Chronic leukaemia
23. Haemoglobinopathy and Inborn errors of metabolism
25. Multiple myeloma
26. Myelodysplastic Syndromes
27. Solid tumours
DATA MANAGEMENT GROUP
27. Data Management
QUALITY MANAGEMENT GROUP
30. Quality management
31. Regulatory issues
32. Sharing best practices
Abstract submissions for the Nurses
Group will not be made under pre-defined topics.
The reviewers will determine relevant Topics during the
Care of the carer
Impact of new therapies on patient care
Information and education
Quality of life
Standards of care